Figure 2.
Correlation between the cumulative dose of methacholine (PD20) and the score of COPD symptoms questionnaire (rs=−0.76, P=0.005) (A), and the number of exacerbations in the previous year (rs=−0.59, P=0.021) (B).
Correlation between the cumulative dose of methacholine (PD20) and the score of COPD symptoms questionnaire (rs=−0.76, P=0.005) (A), and the number of exacerbations in the previous year (rs=−0.59, P=0.021) (B).